Transparency notification

8 October 2026

For Dutch, click here

Transparency notification from UBS Group AG

Antwerp (Belgium), 8 October 2026 – 17:45 CET – In accordance with Article 14 of the Belgian Transparency law of 2 May 2007, Azelis Group NV announces that on 8 October 2026, it has received a transparency notification from UBS Group AG.

1.Summary of the notification

UBS Group AG reported in its notification dated 8 October 2026, that on 6 October 2026, following an acquisition of shares with voting rights and equivalent financial instruments, UBS Group AG (taking into account the holding of all its affiliates), increased its holdings and crossed the threshold of 3.00% in Azelis Group NV. 

On 6 October 2026, UBS Group AG (taking into account the holding of all its affiliates) owned 927,902 shares with voting rights, representing 0.38% of the total number of shares issued by the company (243,921,719), as well as 6,414,850 equivalent financial instruments, representing 2.63% of the voting rights issued by the company.

2.Content of the notification

Reason for the notification

Acquisition or disposal of voting securities or voting rights

Acquisition or disposal of financial instruments that are treated as voting securities

Notification by

A parent undertaking or a controlling person

Persons subject to the notification requirement

NameAddress (for legal entities)
UBS Group AGBahnhofstrasse 45, 8001 Zürich

Date on which the threshold is crossed

6 October 2026

Threshold that is crossed (in %)

3%

Denominator

243,921,719

Notified Details

A) Voting rightsPrevious notificationAfter the transaction
# of voting rights# of voting rights% of voting rights
Holders of voting rightsLinked to securitiesNot linked to the securitiesLinked to securitiesNot linked to the securities
UBS Group AG0  0.00%
UBS AG494,8620.20%
UBS Asset Management (Europe) S.A.97,725  0.04% 
UBS Asset Management Life Limited   8,1280.00% 
UBS Fund Management (Switzerland) AG327,187 0.13% 
Subtotal 927,9020.38% 
TOTAL927,902  00.38%0 

B) Equivalent financial instrumentsAfter the transaction
Holders of equivalent
financial instruments
Type of financial instrumentExpiration dateExercise period or date# of voting rights that may be acquired if the instrument is exercised% of voting rightsSettlement
UBS AGCall Options17-Dec-2027177,0000.07%physical
UBS AGCall Options17-Mar-202861,5000.03%physical
UBS AGRight to Recall Lent sharesAt any time29,4960.01%physical
UBS Switzerland AGRight to Recall Lent sharesAt any time281,3450.12%physical
UBS AGRight of Use over sharesAt any time226,0000.09%physical
UBS Switzerland AGRight of Use over sharesAt any time5,424,5672.22%physical
UBS AG Right to Substitute Shares delivered as Collateral At any time214,9420.09% physical 
 TOTAL6,414,850 2.63% 

TOTAL (A & B)# of voting rights% of voting rights
  CALCULATE 7,342,752 3.01% 

Chain of controlled undertakings through which the holding is effectively held, if applicable 

Please see full chain of control attached.

Additional information

The disclosure obligation arose due to the total indirect holdings of UBS Group AG in Azelis Group NV, held directly by controlled undertakings, going above 3% on 6th October 2026.

3.Further information

The full transparency notifications as well as this press release can be consulted on the Azelis Group NV’s website.

··················· END ···················


 

Contact information: 

Azelis 

investor-relations@azelis.com

About Azelis

Azelis is the reference global innovation service provider in the speciality chemical and food ingredients industry, present in 64 countries across the globe with over 4,100 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a comprehensive portfolio of complementary products to more than 65,000 customers, supported by +2,800 principal relationships, creating a turnover of €4.1 billion (2025). Azelis Group NV is listed on Euronext Brussels under ticker AZE and is included in the BEL20 and BEL®ESG indices.

Across our extensive network of more than 70 application laboratories, our award-winning teams develop innovative and sustainable formulations and provide technical guidance throughout the product development process. We combine global market reach with a local footprint to offer reliable, integrated, and unique digital services to local customers and attractive business opportunities to principals. Recognised for our sustainability leadership, we are committed to responsible growth that positively impacts people, communities and the planet. Through the application of science and deep market expertise, we act as catalysts for innovation, enabling our customers to win and our principals to grow.

Innovation through formulation.

www.azelis.com


 

Attachment – Chain of control

11. Information in relation to the person subject to the notification obligation – organizational

UBS Group AG

UBS AG

UBS Asset Management AG

UBS Asset Management (Europe) S.A.

-

UBS Group AG

UBS AG

UBS Asset Management AG

UBS Asset Management Holding (No. 2) Ltd

UBS Asset Management Holding Ltd

UBS Asset Management Life Ltd

-

UBS Group AG

UBS AG

UBS Asset Management AG

UBS Asset Management Switzerland AG

UBS Fund Management (Switzerland) AG

-

UBS Group AG

UBS AG

UBS Switzerland AG